مباشر

Clinical OMICsHave Microbubbles Burst Through the Barriers of Genetic Medicine Delivery?Clinical OMICsOLE Identified as a Potential Alzheimer’s Therapy Targeting Microglia Endpoints NewsFDA gives rejected drugs another chance in post-Makary era Clinical OMICsAI Discovers Two New Antibiotics for Drug-Resistant Gonorrhea Clinical OMICsGLP-1 Drugs Reduce Crime-Linked Behavior Clinical OMICsMacrophage EGFR Activity Linked to Immune Suppression, Tumor Growth in Colorectal Cancer Clinical OMICsUnexpected Role for RNA Editing in Cancer Immune Evasion Uncovered Clinical OMICsProactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome Clinical OMICsCAR T Success Hinges on Microenvironment Response in GBM Endpoints NewsFDA warns telehealth companies over compounded GLP-1s BioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDA BioWorldAppointments and advancements for June 17, 2026

Clinical OMICs ١٧ يونيو ٢٠٢٦

Proactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome

Proactive surveillance for Li-Fraumeni syndrome is associated with better survival outcomes and nearly nine-fold lower healthcare costs than treating cancer aft...

Proactive surveillance for Li-Fraumeni syndrome is associated with better survival outcomes and nearly nine-fold lower healthcare costs than treating cancer after diagnosis. The post Proactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome appeared first on Inside Precision Medicine .